Abbott Total Assets increased by 27.3% to $110.43B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 35.6%, from $81.45B to $110.43B. Over 5 years (FY 2020 to FY 2025), Total Assets shows an upward trend with a 3.6% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Growth generally indicates business expansion, while a decline may suggest asset liquidation or a contraction in business scale.
This is the sum of all current and non-current assets owned by the company, representing the total resource base availab...
Universal financial metric used by all public companies to define the size of the balance sheet.
total_assets| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $73.27B | $73.80B | $75.20B | $74.01B | $74.20B | $72.80B | $74.44B | $73.79B | $73.35B | $72.09B | $73.21B | $72.47B | $73.02B | $74.36B | $81.41B | $81.45B | $84.00B | $84.18B | $86.71B | $110.43B |
| QoQ Change | — | +0.7% | +1.9% | -1.6% | +0.3% | -1.9% | +2.2% | -0.9% | -0.6% | -1.7% | +1.6% | -1.0% | +0.8% | +1.8% | +9.5% | +0.0% | +3.1% | +0.2% | +3.0% | +27.3% |
| YoY Change | — | — | — | — | +1.3% | -1.3% | -1.0% | -0.3% | -1.1% | -1.0% | -1.6% | -1.8% | -0.5% | +3.1% | +11.2% | +12.4% | +15.0% | +13.2% | +6.5% | +35.6% |
| Segment | Q4 '22 | Q4 '23 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Medical Devices | $7.84B | $9.03B | $9.47B | $10.03B | $10.56B | $10.58B | $10.69B | $10.98B |
| Diagnostic Products | $7.99B | $7.77B | $7.68B | $7.84B | $8.18B | $8.20B | $8.27B | $9.63B |
| Nutritional Products | $3.63B | $4.27B | $4.40B | $4.64B | $4.91B | $4.89B | $4.79B | $4.90B |
| Established Pharmaceuticals | $2.88B | $3.12B | $3.09B | $3.45B | $3.73B | $3.73B | $3.54B | $3.67B |
| Total | $74.44B | $73.21B | $81.41B | $81.45B | $84.00B | $84.18B | $86.71B | $110.43B |